Okami Medical Highlights Growing Clinical Engagement Around LOBO Vascular Occlusion System

A LinkedIn post from Okami Medical centers on the conclusion of the SIR2026 medical conference and highlights engagement with its LOBO vascular occlusion system. The post specifically acknowledges clinical work conducted by teams at the University of North Carolina and the University of Chicago, suggesting growing academic interest in generating evidence around the LOBO system.

The company’s LinkedIn post emphasizes hands-on exposure to the LOBO system through booth visits, a lunch symposium, a workshop, and a technology suite, indicating multi-format physician outreach. For investors, this focus on clinical evidence development and direct engagement with interventional specialists may signal efforts to strengthen physician adoption, support reimbursement arguments, and enhance the product’s competitive position in the vascular occlusion market over the medium term.